11 However, GLP-1s alone are not a strategy they must be embedded within a broader obesity management framework that includes employer support through benefit design, clinical partnerships, behavioral programs and data-driven governance to ensure long-term adherence and meaningful health outcomes
doi:10.3389/fnmol.2021.697440 57
doi: 10.1172/jci.insight.89780 318 KistemakerLEvan OsRPDethmers-AusemaABosISHylkemaMNvan den BergeMet al
Rights and permissions About this article Cite this article Mustikaningtyas, D., Widyarti, S., Rifai, M
Especificaciones tcnicas Nombre: Retatrutida (LY3437943) Clase: Triple agonista de incretinas (GLP-1R / GIPR / GcgR) Presentacin: 20mg polvo liofilizado por vial Pureza: 99% (HPLC) Forma fsica: Polvo blanco liofilizado Almacenamiento sin reconstituir: -20C, protegido de la luz y la humedad Almacenamiento reconstituido: 2C a 8C, usar en 28 das Diluyente recomendado: agua bacteriosttica (0.9% alcohol benclico) Almacenamiento y reconstitucin Sin reconstituir: conservar a -20C en envase hermtico sellado, protegido de la humedad y la luz UV
They require prescription, medical supervision, and ongoing monitoring